Skip to main content
SpringerLink
Log in

Risks of serious hypoglycaemia with antidiabetics assessed

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Users of dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 inhibitors and sodium-glucose co-transporter 2 inhibitors were excluded from this study.

Reference

  • Leonard CE, et al. Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study. Pharmacoepidemiology and Drug Safety : [10 pages], 6 Nov 2017. Available from: URL: http://dx.doi.org/nz/10.1002/pds.4337

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risks of serious hypoglycaemia with antidiabetics assessed. Reactions Weekly 1679, 10 (2017). https://doi.org/10.1007/s40278-017-38735-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-38735-x

Search

Navigation